India suspends another drugmaker's licence over tainted cough syrupIndia has suspended a drugmaker's manufacturing licence after the World Health Organization flagged contamination in its cough syrups found...
25 Jul, 2023, 04.35 PM IST
Twelve stocks in focus in Tuesday's tradeIndian markets are expected to trade in a range. Here is a list of twelve stocks which are likely to remain in focus today.
02 Jun, 2015, 07.48 AM IST
Ranbaxy may launch generic of Novartis’ Diovan in US soonThis launch, pending since September 2012 when Novartis lost patent protection, could happen as early as May, one of the people quoted abov...
25 Apr, 2014, 04.00 AM IST
Ranbaxy suspends shipments of active ingredients from Toansa, Dewas plantsRanbaxy Laboratories said Tuesday it was suspending shipments from two of its plants following US import bans on its products over safety c...
26 Feb, 2014, 02.36 AM IST
Ranbaxy recovers from fall; suspends shipments from two plantsReacting to the news, shares of the drug maker plunged as much as 2.3 per cent in trade on the BSE, but recouped early morning losses quick...
25 Feb, 2014, 10.12 AM IST
Ranbaxy's Toansa plant under Indian drug regulator's watch tooIndia’s drug regulator has ordered Ranbaxy to furnish a comprehensive explanation for the violation of manufacturing practices at its Toans...
30 Jan, 2014, 04.00 AM IST
Is Ranbaxy a contra buy? Stock slips 19% on USFDA import alertRanbaxy Laboratories Ltd plunged as much as 19.90 per cent in trade on Friday, after the US Food and Drug Administration import alert.
24 Jan, 2014, 05.39 PM IST
Ranbaxy plunges 20% as USFDA halts drug imports from Toansa plantRanbaxy Labs plunged as much as 19.69% , after the USFDA ban effectively stops the company from shipping drugs from its Toansa plant.
24 Jan, 2014, 09.51 AM IST
- Ranbaxy starts generic Lipitor shipments from India
Ranbaxy Laboratories Ltd has started exports of a copycat version of blockbuster cholesterol drug Lipitor from a new facility in India.
02 Apr, 2012, 02.59 PM IST
- Ranbaxy gets USFDA nod to sell Lipitor
The approval marks an end to months of uncertainty surrounding approval of the drug which could earn Ranbaxy over $500 mn. Stock quote
01 Dec, 2011, 09.58 AM IST
- Ranbaxy may be allowed to sell Lipitor version in US; pay $350-400 million to settle outstanding issues with US FDA
Ranbaxy and the US FDA are inching toward a settlement over the Indian drug maker’s regulatory troubles in the world’s largest drug market.
25 Nov, 2011, 03.47 AM IST
- Drug cos eye US entry after FDA checks
The US drug regulator has inspected the manufacturing plants of at least half-a-dozen Indian drugmakers, raising hopes that these companies...
05 Jul, 2011, 02.58 AM IST
- USFDA inspects Ranbaxy's new plant in Mohali
The USFDA did not respond to an e-mail query. The company's share price closed at 515.05, down 2.95% at the Bombay Stock Exchange on Wednes...
24 Jun, 2011, 03.31 AM IST
- Govt may make registration of drug brands mandatory
Move to help regulate brands to avoid duplication & confusion.
21 Oct, 2010, 03.49 AM IST
- Atul Sobti to step down as Ranbaxy CEO & MD?
Arun Sawhney, president global pharmaceutical business is seen as a contendor to take over Sobti's position. Sobti was more of an interim C...
12 Aug, 2010, 11.48 AM IST
- Ranbaxy may wind up Mohali unit
The company sources products from local units now; may outsource manufacturing.
18 Jun, 2010, 03.56 AM IST
- Ranbaxy seeks to sell drugs from new Mohali plant in US
Ranbaxy Laboratories has filed for US Food and Drug Administration's (USFDA) approval to sell medicines from its upcoming manufacturing uni...
02 Aug, 2008, 12.01 AM IST